Greenline Partners’s Tenet Healthcare THC Stock Holding History

Greenline Partners’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4	Closed	-$538	–	522
2025 Q1	$538	Buy	+4	New	+$527	﹤0.01%	463

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Greenline Partners's THC Position: Q2 2025 in Review

Greenline Partners sold out of Tenet Healthcare (THC) in Q2 2025, closing a stake of 4 shares — an estimated $538 sold.

Greenline Partners first reported a position in THC in Q1 2025 and held it in 1 quarter. The position peaked at $538 in Q1 2025. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

Greenline Partners reported no remaining Tenet Healthcare position as of Q2 2025 after selling out during the quarter.
Greenline Partners sold 4 Tenet Healthcare shares in Q2 2025, an estimated $538.
Greenline Partners first reported a position in Tenet Healthcare in Q1 2025 and held it in 1 quarter.
Greenline Partners's Tenet Healthcare position peaked at $538 in Q1 2025.
626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on Greenline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.